oxazolidinones

Susceptibility
In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
Laura Lawrence, Paul Danese, Joe DeVito, Francois Franceschi, Joyce Sutcliffe
Mechanisms of Resistance
Linezolid Resistance in Staphylococcus aureus: Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances
Silke Besier, Albrecht Ludwig, Johannes Zander, Volker Brade, Thomas A. Wichelhaus
LETTERS TO THE EDITOR
In Vitro-Selected Linezolid-Resistant Mycobacterium tuberculosis Mutants
Doris Hillemann, Sabine Rüsch-Gerdes, Elvira Richter
Experimental Therapeutics
In Vivo Efficacy of Ceftaroline (PPI-0903), a New Broad-Spectrum Cephalosporin, Compared with Linezolid and Vancomycin against Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus in a Rabbit Endocarditis Model
Cédric Jacqueline, Jocelyne Caillon, Virginie Le Mabecque, Anne-Françoise Miègeville, Antoine Hamel, Denis Bugnon, James Yigong Ge, Gilles Potel
Experimental Therapeutics
In Vivo Efficacy of a Novel Oxazolidinone Compound in Two Mouse Models of Infection
Charles J. Gill, George K. Abruzzo, Amy M. Flattery, Andrew S. Misura, Ken Bartizal, Emily J. Hickey
Clinical Therapeutics
Comparative Study of the Effects of Pyridoxine, Rifampin, and Renal Function on Hematological Adverse Events Induced by Linezolid
Alex Soriano, Mar Ortega, Sebastián García, Georgina Peñarroja, Albert Bové, Miguel Marcos, Juan C. Martínez, José A. Martínez, Josep Mensa
Experimental Therapeutics
Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm
Issam Raad, Hend Hanna, Ying Jiang, Tanya Dvorak, Ruth Reitzel, Gassan Chaiban, Robert Sherertz, Ray Hachem
Experimental Therapeutics
Single-Dose Oral Amoxicillin or Linezolid for Prophylaxis of Experimental Endocarditis Due to Vancomycin-Susceptible and Vancomycin-Resistant Enterococcus faecalis
Philippe Moreillon, Walter R. Wilson, Roland Leclercq, José M. Entenza
Mechanisms of Resistance
First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis
Elvira Richter, Sabine Rüsch-Gerdes, Doris Hillemann
Experimental Therapeutics
Pharmacokinetic/Pharmacodynamic Factors Influencing Emergence of Resistance to Linezolid in an In Vitro Model
Lauren M. Boak, Jian Li, Craig R. Rayner, Roger L. Nation

Pages